Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 19, 2024 04:00 ET | Source: AKAMPION

Thermosome Presents Encouraging Initial Clinical Data from Phase I Trial of Lead Compound THE001

THE001 safe and well tolerated in first two dose level, demonstrating encouraging signs of clinical activityData presented at The Connective Tissue Oncology Society (CTOS) Annual Meeting 2024 Munich,...